Petrus Trust Company, Lta Pfizer Inc Transaction History

Petrus Trust Company, Lta

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $337,553 - $387,619	13,038 New	13,038 $361,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $262,050 - $303,186	7,255 New	7,255 $266,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $229,076 - $268,758	-7,215 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $217,315 - $263,636	7,215 New	7,215 $236,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $197,967 - $282,852	-7,324 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $60,463 - $78,403	1,861 Added 34.07%	7,324 $263,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $204,862 - $225,075	5,463 New	5,463 $232,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $286,755 - $326,932	-7,454 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $40,260 - $48,834	-1,168 Reduced 13.55%	7,454 $328,000
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $64,640 - $68,913	1,960 Added 29.42%	8,622 $313,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $212,584 - $246,627	6,662 New	6,662 $236,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.